Clinical trials
Lymphoma, T-Cell trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 3 |
| Unknown status | 3 |
| Completed | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 2 |
| Advice Pharma Group srl | 1 |
| Hebei Senlang Biotechnology Inc., Ltd. | 1 |
| M.D. Anderson Cancer Center | 1 |
| Ou Bai, MD/PHD | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
| University of Medicine and Dentistry of New Jersey | 1 |
| Weprom | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell | 9 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Immunoblastic Lymphadenopathy | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Enteropathy-Associated T-Cell Lymphoma | 2 |
| Hodgkin Disease | 2 |
| Lymphoma | 2 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, Extranodal NK-T-Cell | 2 |
| Lymphoma, Large-Cell, Anaplastic | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.